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Much of the research in Alzheimer’s disease (AD) that uses mouse models focuses on the
early-onset form of the disease, which accounts for less than 5% of cases. In contrast,
this study used a late-onset AD model to examine the interaction between increased
dietary zinc (Zn) and the apolipoprotein E (ApoE) gene. ApoE ε4 is overrepresented in
late-onset AD and enhances Zn binding to amyloid-β (Aβ). This study sought to determine
if elevated dietary Zn would impair spatial memory in CRND8 mice (CRND8), as well as
mice who carry both the mutated human amyloid precursor protein (APP) and ApoE ε4
genes (CRND8/E4). Mice were provided with either lab tap water or water enhanced with
10 ppm Zn (ZnCO3) for 4 months. At 6 months of age, spatial memory was measured
by the Barnes maze. CRND8 mice exhibited significant memory deficits compared to WT
mice, as shown by an increased latency to reach the escape box. For the CRND8/E4,
but not the CRND8 mice, those given Zn water made significantly more errors than
those on lab water. During the probe trial for the WT group, those on Zn water spent
significantly less time in the target quadrant than those on lab water. These data suggest
that increased dietary Zn can significantly impair spatial memory in CRND8/E4. WT mice
given Zn water were also impaired on the 24-h probe trial when compared to lab water
WTs. Within the CRND8/E4 group only, levels of soluble Aβ were significantly correlated
with average primary latencies. Within the Zn-treated CRND8/E4 group, there was a
significant correlation between insoluble Aβ and average primary errors. Levels of the zinc
transporter 3, ZnT3, were negatively correlated with soluble Aβ (p < 0.01). These findings
are particularly relevant because increased intake of dietary supplements, such as Zn, are
common in the elderly—a population already at risk for AD. Given the effects observed in
the CRND8/E4 mice, ApoE status should be taken into consideration when evaluating the
efficacy of therapies targeting metals.
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INTRODUCTION
Alzheimer’s disease (AD) is the primary cause of dementia in the
elderly and currently affects more than five million Americans
(Alzheimer’s Association, 2013). The present research focuses on
how the biometals, such as zinc (Zn), copper (Cu), and iron
(Fe), interact with amyloid beta (Aβ)—the key constituent of
the plaques that are characteristic of the disease, which mediates
plaque formation and consequent oxidative damage.
Zn, Cu, and Fe are found in high concentrations in and
around amyloid plaques (Lovell et al., 1998; Maynard et al.,
2005), consistent with the notion that Aβ is a metalloprotein
that possesses binding sites for both Zn and Cu (Bush et al.,
1993; Hesse et al., 1994). Zn has been shown to be particularly
effective in promoting Aβ aggregation (Bush et al., 1993), and the
sequestration of Zn by Aβ leads to an intracellular deficiency of
this metal (Grabrucker et al., 2011). Cu, on the other hand, causes
a shift in the processing of the amyloid precursor protein (APP)
towards the non-amyloidogenic pathway (Borchard et al., 1999)
but once Aβ is present, it binds both Cu and Fe. Therefore, Cu
and Fe binding is problematic as these metals are redox-active and
Aβ reduces both metals, resulting in the production of hydrogen
peroxide (H2O2; Huang et al., 1999). H2O2 further reacts with
the reduced metal to produce hydroxyl radicals that can cause
oxidative damage (Bush, 2003). Both aging and plaque-related
inflammation may promote a more acidic brain environment,
which is conducive to Fe and/or Cu binding (Atwood et al., 1998).
Evidence suggests that Zn is crucial for Aβ deposition, and the
presence of Zn in vitro prevents the proteolytic degradation of
Aβ1−42 by matrix metalloprotease 2 (Crouch et al., 2011). Zn also
inhibits the activity of alpha-secretase and promotes gamma- and
beta-secretase activity (Capasso et al., 2005). The zinc transporter,
ZnT3, is responsible for loading zinc into the synaptic vesicles
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(Palmiter et al., 1996; Cole et al., 1999; Linkous et al., 2008).
Eliminating synaptic Zn by genetic ablation of zinc transporter
3 (ZnT3) in an AD mouse model resulted in a 50% reduction
in amyloid (Lee et al., 2002). ZnT3 levels, however, have been
shown to decrease as a function of age and AD (Adlard et al.,
2010). Interestingly, Bjorklund et al. (2012) found that in brains
exhibiting AD neuropathology, ZnT3 levels were lowest in those
patients who received a diagnosis of AD, while those who did not
receive a diagnosis had ZnT3 levels similar to those of healthy
controls.
Given the complexity of biometals in AD, the behavioral
outcome due to changes in metal levels is difficult to predict,
but this has been studied in various mouse models. Long-term
dietary Zn enhancement in transgenic (Tg) mouse models of AD
(TgCRND8, Tg2576, and APP/presenilin 1 (PS1) mouse models)
has been shown to result in cognitive deficits (Linkous et al.,
2009; Railey et al., 2011), as well as an increase in both brain
Zn levels and the number and size of Zn-positive plaques in the
cortex and hippocampus (Wang et al., 2010). Other findings have
found that a severe Zn deficiency (<10 ppm Zn) enlarged amyloid
plaques (Stoltenberg et al., 2007); thus either an overabundance or
deficiency in Zn can potentiate amyloid deposition.
The observations derived from these early-onset mouse mod-
els may be of diminished utility for the majority of AD cases that
are classified as late-onset (manifest after age 65 years) (Harvey
et al., 2003). The emphasis on early-onset genetics dominating
AD research is due to the strong relationship between those genes
and development of the disease. Genetic linkages to the late-onset
form of AD are less specific, but the ε4 allele of the apolipoprotein
E (ApoE) gene has been identified as a major risk factor (Saunders
et al., 1993; Blacker et al., 1998; Huang and Mucke, 2012). The
ApoE gene has three alleles (ε2, ε3, and ε4) resulting in three
isoforms of the protein (Zannis et al., 1981), with ApoE ε4
overrepresented in patients with late-onset AD (Weisgraber and
Mahley, 1996). While ApoE ε4 is considered a susceptibility factor
it does not guarantee the development of disease (Weisgraber
and Mahley, 1996). The exact mode of action of ApoE ε4 in
AD remains elusive. One proposed mechanism is the interaction
between ApoE ε4 and Aβ, which may increase plaques and/or
impede Aβ clearance (Mahley et al., 2006). Amongst those with
AD, ApoE ε4 carriers typically have a larger number of plaques
than ApoE ε3 carriers (Schmechel et al., 1993). Similarly, ApoE ε4
mice that overexpress human APP have an elevation in Aβ plaque
deposition, reduced numbers of presynaptic terminals, and an
impairment in learning and memory tasks as compared to their
ε3 counterparts (Huang, 2006).
The ApoE alleles differ at two residues: ε2 (Cys112, Cys158), ε3
(Cys112, Arg158), and ε4 (Arg112, Arg158) (Rebeck et al., 2002).
Cysteine binds to Zn and Cu with high affinity and the Zn binding
site on APP is located in a cysteine-rich area (Bush and Tanzi,
2002). The increased number of cysteine residues in ε2 and ε3 cor-
relates with their ability to bind zinc in the synaptic cleft and may
contribute to the protective effect of these alleles by preventing
zinc binding to Aβ (Lee et al., 2010). ApoE ε4 is also implicated in
the formation of neurofibrillary tangles (NFTs). It may increase
the phosphorylation of the tau protein (Harris et al., 2004) and
Zn may be a key modulator of this process (Craddock et al., 2012).
Through their relatively high-binding affinity for zinc, Aβ plaques
will cause a reduction in intracellular levels of zinc that will in
turn lead to a destabilization of microtubules and subsequent
liberation of tau (Craddock et al., 2012). These findings suggest
that Zn and ApoE ε4 may act together to affect multiple processes
in AD through the promotion of NFT formation and increased
Aβ deposition, which may be due to increased Zn binding in the
presence of ApoE ε4.
In order to examine the effect of excess zinc in the more
prevalent form of AD we have developed a late-onset model,
examining two types of Tg mice with the (1) humanized ApoE
ε4 and mutated hAPP cross (CRND8/E4); or (2) those only
with mutated hAPP (CRND8), and investigated the effect of Zn
supplementation on spatial memory in these mice. Protein levels
of soluble and insoluble Aβ, and ZnT3 were measured to elucidate




To address the primary research questions of the study, the
creation of a mouse strain modeling late-onset AD was necessary.
The CRND8/E4 experimental animals were obtained by breeding
CRND8 males (University of Toronto) with female mice who were
homozygous for the human ApoE ε4 knock-in and the knock-
out of murine ApoE (Jackson Labs). Resultant CRND8/E4 were
therefore heterozygous for human ApoE ε4 and murine ApoE
in addition to being hemizygous for the hAPP mutation. Tg
CRND8 mice carry a mutant form of APP 695 containing both the
Swedish (KM670/671NL) and Indiana (V717F) mutations on a
hybrid C3H/B6 genetic background and exhibit extensive amyloid
deposition by 3 months of age. There is a potent increase in
Aβ42 at around 10 weeks of age in this model making the Aβ42
to Aβ40 ratio 5:1 (Chishti et al., 2001). The Tg1HolApoetm1unc/J
strain expresses human ApoE ε4 under the direction of human
glial fibrillary acidic protein (GFAP). Experimental WT mice were
those littermates who did not inherit the hAPP transgene from the
cross between CRND8 males and WT females (C3H/B6). CRND8
mice were those offspring who inherited the hAPP transgene from
the CRND8 males that were bred with WT females.
Mice were bred in three groups in order to facilitate behavioral
testing. The offspring were group housed with same-sex litter-
mates with 2–4 animals per cage. Each cage contained an igloo,
nylabone, and running wheel (Bio-serv). The mouse colony was
maintained with a 12-h light/dark cycle. Food (Harlan diet 7012)
and water were provided ad libidum.
Behavioral group numbers are shown in Table 1. This study
used both male and female mice, and analyses were conducted
to determine possible sex differences. Zn supplementation began
at 6 weeks of age and continued throughout behavioral testing.
Behavioral testing began at 5 months of age and mice were
sacrificed within 10 days following the conclusion of all behavioral
testing (approximately 6 months of age). Mice were euthanized by
CO2 asphyxiation and brains were removed and stored in a −80◦
freezer for later analysis. There were no differences in body weight
on the day of euthanasia when evaluated by water condition.
All experiments and procedures performed on these mice were
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Table 1 | Group distributions and male to female ratio for Barnes
maze (BM) and Western blot (WB) analyses.
Group BM N = BM m:f WB N = WB m:f
WT + Lab Water 12 7:5 0 n/a
WT + Zn 12 6:6 0 n/a
CRND8/E4 + Lab Water 11 6:5 10 5:5
CRND8/E4 + Zn 11 5:6 11 5:6
CRND8 + Lab Water 12 8:4 10 6:4
CRND8 + Zn 11 9:2 9 7:2
approved by the George Mason University Institutional Animal
Care and Use Committee.
WATER PREPARATION
The 10 ppm ZnCO3 was supplemented to laboratory tap water
(herein referred to as Zn water) and was prepared using a starting
solution of 10,000 mg/L of zinc dissolved in 5% HNO3. The final
solution was buffered with Na2CO3 to bring it to a pH of 7.0
(Linkous et al., 2009). All waters were made and stored in separate
polycarbonate carboys and dispensed to animals in 500 mL glass
bottles. Water was analyzed regularly using inductively coupled
plasma-optical emission spectroscopy and ion chromatography
at the United States Geological Survey (USGS, Reston, VA) to
confirm metal content. Laboratory tap water without any sup-
plement, herein referred to as lab water, was used for the con-
trol group. Water consumption was measured every week and
there were no significant differences when evaluated by water
condition.
BARNES MAZE
The Barnes maze (BM) is designed to assess spatial memory. The
maze (Med Associates) consisted of an elevated platform 122 cm
in diameter (91 cm above the ground) with 40 equidistant holes
located around the edges. The maze’s surface color was white. An
escape box was located under one of the holes and four distinctive
extra-maze reference cues were placed around the maze, with one
on each side (large black letters on a white background). Testing
took place in a brightly illuminated room with a 300-watt light
situated directly over the maze in order to make the maze surface
undesirable, given the natural tendency of mice to prefer dark
enclosed areas over bright/open areas. All animals started each
trial from a dark enclosed start box positioned in the center of the
maze. The orientation of the start chamber was varied for each
trial. The maze was cleaned with 70% ethanol solution between
all trials to eliminate scent trails.
Procedure
BM testing took place over seven consecutive days with the 24-h
probe trial occurring on the seventh day.
Habituation: On the first day of testing all mice were given two
habituation trials. The mice were placed in a start chamber in the
center of the maze for 10 s after which time the start box was lifted
and they were gently guided to the escape box and allowed to enter
on their own. Once inside, mice stayed in the escape box for 30 s
before being returned to their home cage for a 2 min inter-trial
interval.
Acquisition: Days 2–6 were acquisition days. The mice received
three trials per day with a 15 min inter-trial interval. The
trials on the acquisition days ended when the animal entered
the escape box or when the maximum trial length of 3 min
was reached. Mice were allowed 30 s in the escape box after
locating it. If the animal did not find the escape box in the
allotted 3 min trial period they were gently guided to the escape
box and allowed 30 s inside. Primary latency (amount of time
elapsed prior to first reaching target hole) and primary errors
(number of errors made prior to reaching target hole) were
measured.
Probe Trial: On day 7 the animals received one probe trial 24 h
after the last training trial. The escape box was removed from the
target hole that had been previously learned and the mice were
given 3 min to explore the maze. Percent of time in the correct
quadrant was measured.
TISSUE PREPARATION
Frozen brain samples were minced into small pieces and homog-
enized in 1 mL of a mixture of PBS and protease/phosphatase
inhibitor cocktail (Sigma-Aldrich). The homogenate was then
centrifuged at 4◦C at 24,000 RPM for 1 h. Soluble and insol-
uble fractions were separated. The insoluble fractions were
additionally reconstituted in 1 mL of a mixture of PBS and
protease/phosphatase inhibitors. Both soluble and insoluble
fractions were then lyophilized for approximately 12 h until fully
dehydrated.
WESTERN BLOT ANALYSES
For Western blot (WB) analysis, lyophilized insoluble fractions
were reconstituted in 250 µL of PBS and protease/phosphatase
inhibitor cocktail. Soluble fractions were reconstituted in 50 µL
of PBS and cocktail. A BCA protein assay was done to determine
protein concentration for each sample. Fifteen microliters of
samples were heated at 90◦C for 10 min and then spun down
and loaded onto Criterion XT precast 4–12% gels. After the gels
were run and transferred to a PVDF membrane they were blocked
in 5% tris buffered saline with Tween20 (TBST) skim milk for
1 h. The membranes were then briefly rinsed with TBST and
incubated overnight at 4◦C with the following primary anti-
bodies: WO2 (1:2000; in-house antibody prepared at The Florey
Institute of Neuroscience and Mental Health); ZnT3 (1:10,000, in-
house antibody prepared at The Florey Institute of Neuroscience
and Mental Health); and GAPDH (1:10,000; Millipore Cat: MAB
374). After three washes of TBST for 5–10 min, secondary anti-
body incubation was performed (polyclonal rabbit anti-mouse
IgG conjugated to horseradish peroxidase (HRP); 1:10,000; Dako
P0260) at room temperature for 1 h. Three additional washes
of TBST were done before enhanced chemiluminescent substrate
was added for imaging using Multigauge software (Fujifilm).
After imaging, the membranes were briefly rinsed with TBST
and then the membranes were stripped using Re-blot Plus Strong
solution (Millipore). The bands were scanned and the intensities
of the bands were measured using the Fuji Reader LAS-4000.
Protein levels for WO2 and ZnT3 were normalized to GAPDH
(Figure 5).
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STATISTICAL ANALYSES
Statistical differences among different genotypes and water con-
ditions against measured behavioral parameters were determined
by repeated-measures analysis of variance (RMANOVAs). When
necessary, Greenhouse-Geisser estimates of sphericity were used
to correct for degrees of freedom. Bonferroni post-hoc tests were
used to evaluate group differences. Correlations between protein
levels and measured behavioral parameters were calculated using
the Pearson correlation coefficient (r). Data are expressed as mean
± SEM. A significance level of p < 0.05 was used for all analyses.
Trends were reported at a level of p< 0.10.
RESULTS
BARNES MAZE BEHAVIOR
Three genotypes (WT, CRND8/E4, CRND8) × two water con-
ditions (lab water and zinc water) mixed design RMANOVAs
were performed for measures of primary latency, primary errors,
and percent of time in the target quadrant for the 24-h probe
trial. Between group variables were genotype and water type.
The within subjects variable was testing day (five levels). Sex was
entered as a covariate for all statistical analyses.
On days 1–5, there was a significant within-subjects effect
of day for primary latency (F(3.03,172.43) = 44.29, p < 0.001)
indicating overall improvement across testing days for all groups.
There was a significant effect on primary latency between geno-
types (F(2,57) = 4.124, p < 0.05). A Bonferroni post-hoc test
revealed that primary latencies across days 1–5 were significantly
shorter for WT mice as compared to CRND8 mice (p < 0.05),
but not compared to CRND8/E4. The CRND8/E4 were also not
significantly different from CRND8 mice (Figure 1A). On average
CRND8/E4 animals had latencies that were shorter than CRND8
animals, but longer than WT animals. For primary latency, there
were no main effects of water condition.
On days 1–5, there was a significant within-subjects effect
of day for primary errors (F(3.39,200.0) = 23.32, p < 0.001). For
primary errors there were no significant main effects of water
or genotype across all groups on days 1–5 or during probe
trials (Figure 1B). Further analyses within genotypes revealed no
significant differences between Zn water and lab water in WT and
CRND8 mice (Figures 2A,B). However, within the CRND8/E4
genotype there was a significant main effect of water. CRND8/E4
mice on Zn water made significantly more primary errors than
those CRND8/E4 on lab water on days 2–3 (F(1,17) = 5.64,
p< 0.05; Figure 2C).
There were no significant main effects of genotype on the
24-h probe trial. There was, however, a significant main effect
of water condition within the WT group. Zn water WT mice
spent significantly less time than lab water WT mice in the target
(correct) quadrant (23% vs. 41% respectively) (F(1,21) = 3.28,
p < 0.05; Figure 3). Both CRND8/E4 and CRND8 groups raised
on either Zn or lab water scored close to chance during the probe
trial.
In summary, there were significant main effects of water
condition within the CRND8/E4 and WT genotypes, but not
in the CRND8 group. As predicted, Zn water CRND8/E4 mice
had higher primary errors in the BM compared to those on lab
water. Significant genotype differences did exist between CRND8
FIGURE 1 | Average primary latency and primary errors across
genotypes in the Barnes maze, regardless of water condition.
(A) Average primary latencies were significantly shorter for WT mice as
compared to CRND8 mice (p < 0.05), but not CRND8/E4s. Overall, there
was a significant decrease across days in primary latency for all genotypes
(p < 0.001). (B) Average primary errors in the Barnes maze. Primary errors
were not significantly different between any of the genotypes. All groups
did, however, improve significantly over time (p < 0.001). Points are mean ±
SEM. * denotes p < 0.05.
mice compared to WT mice on measures of primary latency,
as was expected. Mice carrying both the ApoE ε4 and mutated
hAPP genes were not more impaired than the CRND8 transgene.
However, on the primary error measure, CRND8/E4 mice on Zn
water had the highest number of primary errors. WT mice on
Zn water were spent significantly less time in the target quadrant
when compared to those WTs on lab water.
PROTEIN ANALYSIS
Relative levels of soluble Aβ, insoluble Aβ, and ZnT3 were
obtained from WB analysis. This analysis was conducted only on
Tg mice (CRND8 and CRND8/E4). The control for both Tg
groups was a CRND8/E4 in the lab water group which may
explain why all significant correlations with behavior were
seen only in the CRND8/E4 group; all protein correlations pre-
sented here are within that genotype only. There were no sig-
nificant main effects for water and genotype. There were no
significant main effects on levels of ZnT3. There were also no
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FIGURE 2 | Average primary errors for all genotypes. There were no significant differences between Zn and Lab water (A) WT and (B) CRND8 mice. (C)
Within the CRND8/E4 mice, however, those on Zn water had significantly more primary errors than the lab water group on days 2 and 3 (p < 0.05). Points are
mean ± SEM. * denotes p < 0.05.
FIGURE 3 | Percent of time spent in the target quadrant in the Barnes
maze. WT mice on Zn water spent significantly less time in the target
quadrant during the 24-h probe trial when compared to lab water WT mice
(p < 0.05). Tg mice consistently scored at or below chance levels. Points
are mean ± SEM. * denotes p < 0.05.
significant main effects for soluble Aβ or insoluble Aβ. Regardless
of water condition, however, levels of soluble Aβwere significantly
correlated with the average primary latencies for day 3 (r = 0.657,
p < 0.01) and day 4 (r = 0.463, p < 0.05; Figure 4A). Those
mice on Zn water had levels of insoluble Aβ that were significantly
correlated with average primary errors for day 3 (r = 0.754, p <
0.01) and day 5 (r = 0.658, p< 0.05; Figure 4B). Those on control
lab water had soluble Aβ levels which significantly correlated
with the average primary latency on day 3 (r = 0.712, p < 0.05;
Figure 4C). Mice on Zn water had levels of soluble Aβ that were
negatively correlated with levels of ZnT3 (r = −0.791, p < 0.01;
Figure 4D).
DISCUSSION
These data show that the performance of the mice modeling late-
onset AD depended significantly upon the presence or absence
of Zn in the drinking water. Overall, CRND8/E4 mice did not
perform worse than the CRND8 mice, as had initially been
predicted. However, CRND8/E4 mice raised on Zn water made
the most errors in the BM of all six groups, and also had signif-
icantly increased errors compared to those raised on lab water.
On the primary latency measure, the CRND8 mice performed
significantly worse than the WT mice. The CRND8/E4 group’s
performance was intermediate between the other groups, and did
not differ significantly from either. In contrast to the effect on
primary errors, there was no significant effect of Zn water on
primary latency. The observation that primary errors, and not
primary latencies, detected a Zn effect in the late-onset mouse
model is consistent with O’Leary and Brown (2013) who have
suggested that errors are a more sensitive measure of memory
than latency in the Barnes maze.
The effect on errors may be due to enhanced Zn binding to
Aβ when in the presence of ApoE ε4. ApoE ε4 has the weakest
affinity for binding Zn, due to the amino acid substitution of
arginine which is not a ligand for Zn (Lee et al., 2010). In
contrast, the ApoE ε2 and ApoE ε3 isoforms with cysteine residues
strongly bind Zn, and may prevent it from binding with Aβ, which
could in turn prevent oligomerization and deposition (Lee et al.,
2010). While there are numerous in vitro studies investigating the
association between Zn and ApoE ε4, this is a novel behavioral
study examining the relationship between the two in a mouse
model of late-onset AD.
Zn water did not result in significant latency deficits in the
CRND8 and WT groups. For the WT group, Zn significantly
reduced the percent time spent in the target quadrant for the
24-h probe trial; thus the WT mice on Zn water were impaired
on the most difficult memory task. Neither the CRND8/E4 or
CRND8 groups performed above chance on either water condi-
tion (Figure 4); thus, additional impairments caused by Zn were
difficult to assess. Given the difficulty of the 24-h probe task for
the Tg mice, running probe tests as the last run on alternate days,
as is done in the Morris water maze (MWM), could be a useful
strategy.
We have previously demonstrated significant latency impair-
ments in the MWM in both Zn water rats and Tg (CRND8 and
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FIGURE 4 | Significant correlations in the CRND8/E4 group
showing (A) soluble Aβ vs. average primary latencies for days 3
(r = 0.657, p < 0.01) and 4 (r = 0.463, p < 0.05); (B) In Zn water
mice, insoluble Aβ vs. average primary errors for days 3 (r = 0.754,
p < 0.01) and 5 (r = 0.658, p < 0.05); (C) In lab water mice, soluble
Aβ vs. average primary latency on day 3 (r = 0.712, p < 0.05); and
(D) In Zn water mice, soluble Aβ negatively correlates with ZnT3
(r = −0.791, p < 0.01). ∗ denotes p < 0.05.
Tg2576) mice (Linkous et al., 2009; Railey et al., 2010, 2011). The
MWM is a more stressful test than the BM (Hölscher, 1999) and
this may account for the different effects of zinc on latency seen
in this experiment. Overall, data from our lab indicate that Zn
water has adverse behavioral effects on WT and CRND8 mice
but that additional mechanisms are at work for CRND8/E4 mice.
Although Zn supplementation exacerbated behavioral deficits in
the Tg2576 and CRND8 mice, this led to a paradoxical decrease in
amyloid deposits in the Tg2576 mice (Linkous et al., 2009), which
was also observed by Harris et al. (2014); however they found no
significant behavioral differences.
The deficits in spatial memory that were observed in the
Barnes maze, in connection with dietary Zn supplementation,
may be attributable to the effect of Zn on other metals in
the brain, specifically Cu. Excess dietary Zn prevents adequate
absorption of Cu through the intestinal wall (Milne et al.,
2001). Therefore, Zn supplementation may potentiate a Cu defi-
ciency that is inherent in Tg mice overexpressing mutant hAPP
(Phinney et al., 2003). Brewer (2014), however, found a non-
significant delay in cognitive impairment in AD patients who
received Zn supplements, and suggests that AD is the result of
a Zn deficiency. He also noted that these subjects had relatively
low Zn serum levels and suggested that this would lead to an
overload of copper. Brewer (2014) considers zinc deficiency a
risk factor for AD, due to its interaction with copper (Brewer,
2014).
In contrast, Klevay (2008) has suggested that AD is due to a
Cu deficiency instead of Cu toxicity and spatial memory deficits
in Zn-treated Tg mice can be remediated by the concurrent
administration of small amounts of Cu (Railey et al., 2011). APP-
overexpressing mice have lower levels of Cu in the brain (Bayer
et al., 2003) which would support increasing dietary Cu to treat
AD. This is consistent with another study where APP23 mice were
given Cu supplementation which resulted in a reduction of Aβ
and an increase in superoxide dismutase 1 (SOD1) activity (Bayer
et al., 2003). These conflicting findings from different labs suggest
that metal dyshomeostasis in AD can be due to either a deficiency
or overabundance of metal ions, and that alterations to the levels
of one metal can impact levels of another. The initial metal status
of the patient should be an important factor in considering any
form of dietary metal-based therapy.
In contrast to our observations, Zn supplementation in the
3xTg mouse actually improved performance on behavioral tasks,
and decreased both Aβ and tau pathology (Corona et al., 2010),
while decreased dietary Zn elevated plaque volume in APP/PS1
mice (Stoltenberg et al., 2007). Carrying mutations in PS1, or
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FIGURE 5 | Representative blots are shown for WO2 and ZnT3 which were normalized to GAPDH.
in the case of the 3xTg, a mutation in tau, can alter the ability
of these proteins to interact with metals. The divergent results
may stem from differences in the mouse model used, chemical
composition of zinc solutions, and age of onset and duration
of Zn supplementation. Our mice were given a standard rodent
chow which contains adequate levels of Zn, in addition to the Zn
supplementation, which would be in contrast to the Zn deficiency
that is reported in the elderly population. While Zn therapy may
be beneficial for those with a Zn deficiency, excess Zn, and Zn in
the presence of ApoE ε4, may actually be harmful.
In a mouse model carrying the three different human ApoE
alleles in the 5xTg mouse, the ApoE transgenes delayed pathology
typically observed in the 5xTg strain (Youmans et al., 2012).
Although having an expanded window of time to study the pro-
gression of AD pathology could be useful, using either the 3xTg or
5xTg strains may be contraindicated for studying the effects of Zn
or other metals in late-onset AD. These multiple transgene models
have mutations in PS1, which affects cellular turnover of Zn and
Cu, since PS1 has Zn binding sites, which will affect SOD1 activity
(Sensi et al., 2008; Greenough et al., 2011; Southon et al., 2013).
Therefore, studies looking at the relationship between metals
and pathobiology of late-onset AD should avoid incorporating
mutated PS1 transgenes. Also, enzymes that modulate tau are Zn-
dependent.
The current data did not support the predicted outcome of
more behavioral impairment in CRND8/E4 mice as compared
to CRND8 mice. On most measures the CRND8/E4 mice per-
formed slightly, but not significantly, better than CRND8 mice.
This is consistent with other recent behavioral data in younger
Tg mice modeling late-onset AD (Moreau et al., 2013). Similar
observations of intermediacy were reported in circadian rhythm
and nest building behavior, as well as in markers for inflammatory
cytokines (Graybeal et al., 2014). Recent studies have shown that
any isoform of human ApoE delays AD pathology in early-onset
Tg mice (Youmans et al., 2012; Tai et al., 2013).
One possible explanation for the greater impairment associ-
ated with the ApoE ε4 allele in old age is due to its interaction
with metals and their dysregulation with increased age. Zn and Cu
have an interdependent relationship and they exist in a delicate
homeostasis whereby a shift towards either excess or deficiency
may influence Aβ neurotoxicity. Lee et al. (2012) have shown
that Zn accumulates around dystrophic neurons in aged Tg2576
mice and suggest that this excess Zn “crowded around amyloid
plaques” and could directly cause the death of neurons. Such
an effect would likely be greater in the case of ApoE ε4 which
does not bind Zn and Cu as efficiently as the other forms of
ApoE.
Another interesting finding was that ZnT3, which is the trans-
porter responsible for loading zinc into synaptic vesicles, was
negatively correlated with soluble Aβ levels, which is the more
toxic form of Aβ. Although a general decline in levels of ZnT3 has
been associated with cognitive decline (Bjorklund et al., 2012),
it has also been demonstrated that the regions of brain that
express ZnT3 may change so that the overall level of expression
remains unaltered, but the localization of expression may vary
and be centered more around areas of pathology in the Tg CNS
(Lee et al., 2012). This may explain why no overall differences
for ZnT3 expression were detected. It is notable that within the
Zn water group we observed a correlation between insoluble Aβ
and primary errors, as this may be due to the ability of Zn to
aggregate Aβ. The relationship between amyloid load and learning
and memory remains controversial; for example, Gruart et al.
(2008) found no relationship between hippocampal-dependent
learning and amyloid load, suggesting that other mechanisms may
be involved.
ApoE ablation reduces the amount of ZnT3 and results in
significantly lower levels of synaptic Zn compared to WTs (Lee
et al., 2010). Zn is required for both presynaptic and postsynaptic
mossy fiber long-term potentiation, and dysregulation of synaptic
Zn alters the excitatory input of the mossy fiber-CA3 synapse
in the hippocampus (Pan et al., 2011). Furthermore, ApoE-ε4
targeted replacement mice have altered levels of glutaminase and
vesicular glutamate transporter 1 (Dumanis et al., 2013). ApoE-
ε4 is correlated with decreased dendritic spines (Dumanis et al.,
2009), and treatment of neurons with ApoE-ε4 recombinant
protein reduces expression of glutamate receptors (Chen et al.,
2010). Future research should examine the effects of Aβ, Zn
supplementation, and ApoE status on glutamatergic pathways.
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Since this study demonstrates that CRND8/E4 mice are sensi-
tive to dietary Zn-enhancement, this suggests that therapies tar-
geting metals should consider ApoE allele status in their analyses.
Currently, the only FDA-approved drugs for treating AD work by
alleviating symptoms instead of targeting the underlying etiology
of the disease. A newer class of drugs currently under evaluation,
the 8-hydroxyquinolines (8-OHQ), are selective Zn/Cu chaper-
ones (Greenough et al., 2013). Two drugs in this class, Clioquinol
(CQ) and PBT2 have a higher affinity for binding Zn and Cu
when compared to Aβ. Instead of chelating these metals from
the system, they are able to return metals back inside the cell,
thereby restoring the bioavailability of metal ions necessary for
cellular processes (Adlard and Bush, 2012). This restoration of
intracellular metal concentrations has been shown to increase
synaptic proteins, reduce Aβ accumulation, and improve cogni-
tive functioning in Tg mice (Adlard et al., 2008, 2011; Crouch
et al., 2011).
CONCLUSIONS
This experiment showed that Zn water caused significant impair-
ments in a mouse model of late-onset AD, containing the ApoE
ε4 allele; consequently, studies on the role of metals in AD need to
take into account the ApoE status of either the human subjects or
the mouse models. Furthermore, due to the interaction between
different metals such as Cu and Zn, care needs to be taken when
conducting both in vitro and in vivo studies, where the outcomes
and interpretations of studies may be confounded by this inter-
relationship. Future studies examining the effects of Zn and/or Cu
deficiencies and excesses in the different human ApoE alleles of a
late-onset model of AD is warranted.
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